Canada markets closed

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.15000.0000 (0.00%)
At close: 04:00PM EDT
1.1200 -0.03 (-2.61%)
After hours: 07:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 86.69M
Enterprise Value 52.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.26
Price/Book (mrq)N/A
Enterprise Value/Revenue 6.18
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.44
52-Week Change 3-4.96%
S&P500 52-Week Change 319.61%
52 Week High 32.1200
52 Week Low 30.6500
50-Day Moving Average 31.2487
200-Day Moving Average 31.2292

Share Statistics

Avg Vol (3 month) 3171.38k
Avg Vol (10 day) 3130.22k
Shares Outstanding 574.73M
Implied Shares Outstanding 674.73M
Float 865.17M
% Held by Insiders 17.43%
% Held by Institutions 128.97%
Shares Short (Jun 28, 2024) 4226.92k
Short Ratio (Jun 28, 2024) 41.23
Short % of Float (Jun 28, 2024) 40.32%
Short % of Shares Outstanding (Jun 28, 2024) 40.30%
Shares Short (prior month May 31, 2024) 4275.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,569.13%

Management Effectiveness

Return on Assets (ttm)-37.49%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)8.45M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)5,650.00%
Gross Profit (ttm)N/A
EBITDA -25.37M
Net Income Avi to Common (ttm)-34.97M
Diluted EPS (ttm)-0.5500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.35M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)45.33M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.07
Book Value Per Share (mrq)-0.29

Cash Flow Statement

Operating Cash Flow (ttm)-18.77M
Levered Free Cash Flow (ttm)-17.98M